Works matching AU Kohn, Elise C.


Results: 92
    1
    2

    Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8<sup>+</sup> T cells compared with women with BRCA wild-type disease during the early disease course.

    Published in:
    Oncology Letters, 2019, v. 18, n. 4, p. 3914, doi. 10.3892/ol.2019.10731
    By:
    • Lee, Jung-Min;
    • Botesteanu, Dana-Adriana;
    • Tomita, Yusuke;
    • Yuno, Akira;
    • Lee, Min-Jung;
    • Kohn, Elise C.;
    • Annunziata, Christina M.;
    • Matulonis, Ursula;
    • MacDonald, Lauren A.;
    • Nair, Jayakumar R.;
    • Macneill, Kimberley M.;
    • Trepel, Jane B.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Cancer's deadly signature.

    Published in:
    Nature Genetics, 2003, v. 33, n. 1, p. 10, doi. 10.1038/ng0103-10
    By:
    • Liotta, Lance A.;
    • Kohn, Elise C.
    Publication type:
    Article
    9
    10
    11
    12
    13

    Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.

    Published in:
    Cells (2073-4409), 2019, v. 8, n. 3, p. 200, doi. 10.3390/cells8030200
    By:
    • Bagnoli, Marina;
    • Shi, Ting Yan;
    • Gourley, Charlie;
    • Speiser, Paul;
    • Reuss, Alexander;
    • Nijman, Hans W.;
    • Creutzberg, Carien L.;
    • Scholl, Suzy;
    • Negrouk, Anastassia;
    • Brady, Mark F.;
    • Hasegawa, Kosei;
    • Oda, Katsutoshi;
    • McNeish, Iain A.;
    • Kohn, Elise C.;
    • Oza, Amit M.;
    • MacKay, Helen;
    • Millan, David;
    • Bennett, Katherine;
    • Scott, Clare;
    • Mezzanzanica, Delia
    Publication type:
    Article
    14
    15

    A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25904-w
    By:
    • Konstantinopoulos, Panagiotis A.;
    • da Costa, Alexandre André B. A.;
    • Gulhan, Doga;
    • Lee, Elizabeth K.;
    • Cheng, Su-Chun;
    • Hendrickson, Andrea E. Wahner;
    • Kochupurakkal, Bose;
    • Kolin, David L.;
    • Kohn, Elise C.;
    • Liu, Joyce F.;
    • Stover, Elizabeth H.;
    • Curtis, Jennifer;
    • Tayob, Nabihah;
    • Polak, Madeline;
    • Chowdhury, Dipanjan;
    • Matulonis, Ursula A.;
    • Färkkilä, Anniina;
    • D'Andrea, Alan D.;
    • Shapiro, Geoffrey I.
    Publication type:
    Article
    16
    17
    18
    19

    Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.

    Published in:
    2016
    By:
    • Noonan, Anne M.;
    • Bunch, Kristen P.;
    • Chen, Jin‐Qiu;
    • Herrmann, Michelle A.;
    • Lee, Jung‐Min;
    • Kohn, Elise C.;
    • O'Sullivan, Ciara C.;
    • Jordan, Elizabeth;
    • Houston, Nicole;
    • Takebe, Naoko;
    • Kinders, Robert J.;
    • Cao, Liang;
    • Peer, Cody J.;
    • Figg, W. Douglas;
    • Annunziata, Christina M.;
    • Chen, Jin-Qiu;
    • Lee, Jung-Min
    Publication type:
    journal article
    20
    21
    22
    23
    24
    25
    26

    Ovarian cancer.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 3, p. 474, doi. 10.1002/cncr.27833
    By:
    • Kohn, Elise C.;
    • Hurteau, Jean
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip.

    Published in:
    Drug Development Research, 2000, v. 49, n. 1, p. 34, doi. 10.1002/(SICI)1098-2299(200001)49:1&lt;34::AID-DDR6&gt;3.0.CO;2-W
    By:
    • Paweletz, Cloud P.;
    • Gillespie, John W.;
    • Ornstein, David K.;
    • Simone, Nicole L.;
    • Brown, Monica R.;
    • Cole, Kristina A.;
    • Wang, Quan-Hong;
    • Huang, Jing;
    • Hu, Nan;
    • Yip, Tai-Tung;
    • Rich, William E.;
    • Kohn, Elise C.;
    • Linehan, W. Marston;
    • Weber, Thomas;
    • Taylor, Phil;
    • Emmert-Buck, Mike R.;
    • Liotta, Lance A.;
    • Petricoin, Emanuel F.
    Publication type:
    Article
    33
    34
    35
    36

    Phase l/lb Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju089
    By:
    • Jung-Min Lee;
    • Hays, John L.;
    • Annunziata, Christina M.;
    • Noonan, Anne M.;
    • Minasian, Lori;
    • Zujewski, Jo Anne;
    • Minshu Yu;
    • Gordon, Nicolas;
    • Jiuping Ji;
    • Sissung, Tristan M.;
    • Figg, William D.;
    • Azad, Nilofer;
    • Wood, Bradford J.;
    • Doroshow, James;
    • Kohn, Elise C.
    Publication type:
    Article
    37

    Better Therapeutic Trials in Ovarian Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 4, p. 1, doi. 10.1093/jnci/dju029
    By:
    • Bookman, Michael A.;
    • Gilks, C. Blake;
    • Kohn, Elise C.;
    • Kaplan, Karen O.;
    • Huntsman, David;
    • Aghajanian, Carol;
    • Birrer, Michael J.;
    • Ledermann, Jonathan A.;
    • Oza, Amit M.;
    • Swenerton, Kenneth D.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45

    The new millennium.

    Published in:
    Cancer (0008543X), 2000, v. 88, n. 1, p. 2, doi. 10.1002/(SICI)1097-0142(20000101)88:1&lt;2::AID-CNCR2&gt;3.0.CO;2-K
    By:
    • Brown, Monica R.;
    • Kohn, Elise C.;
    • Hutter, Robert V. P.
    Publication type:
    Article
    46
    47
    48
    49
    50